n-acetylaspartic acid has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choe, BY; Choi, CB; Choi, WS; Jahng, GH; Kim, HY; Kim, SY; Lee, SH; Ryu, KN; Yang, DM; Yim, SV | 1 |
Benner, EJ; Boska, MD; Destache, CJ; Gendelman, HE; Lewis, TB; Mosley, RL; Nelson, JA; Uberti, M | 1 |
2 other study(ies) available for n-acetylaspartic acid and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Dogs; Female; Humans; Male; MPTP Poisoning; Tissue Distribution | 2011 |
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
Topics: Adoptive Transfer; Animals; Aspartic Acid; Cell Count; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glatiramer Acetate; Immunization; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; Microglia; MPTP Poisoning; Myelin Basic Protein; Nerve Degeneration; Nerve Tissue Proteins; Ovalbumin; Parkinsonian Disorders; Peptides; Substantia Nigra; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase | 2005 |